https://reachmarkets.com.au/events/recent-events/prescient-therapeutics-asx-ptx-investor-briefing/
Prescient Therapeutics (ASX: PTX) Webcast Replay - ASX Company Webcasts, Recent Events, Webcast
Oct 13, 2025 - In this session Prescient CEO James McDonnell discusses why the First Patient Dosed marks a significant milestone in the commencement of the PTX-100 Phase 2a...
prescient therapeuticswebcast replayrecent eventsasxptx
https://www.biospace.com/prescient-therapeutics-release-fda-allows-ptx-ind-for-leukemia-phase-ib-and-ii-trials
Prescient Therapeutics Release: FDA Allows PTX IND For Leukemia Phase Ib & II Trials - BioSpace
prescient therapeuticsreleasefdaallowsptx